Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NUVL Nuvalent, Inc.

交易中 07-29 11:31:53 EDT

81.60

-0.34

-0.41%

最高83.50	最低80.27	成交量8.54万
今开82.19	昨收81.94	日振幅3.94%
总市值58.60亿	流通市值33.67亿	总股本7,181万
成交额695.13万	换手率0.21%	流通股本4,126万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":81.6,"timestamp":1753803069234,"preClose":81.94,"halted":0,"volume":85384,"delay":0,"floatShares":41261610,"shares":71808765,"eps":-4.406658,"marketStatus":"交易中","change":-0.34,"latestTime":"07-29 11:31:53 EDT","open":82.19,"high":83.495,"low":80.27,"amount":6951334.29224,"amplitude":0.039358,"askPrice":81.62,"askSize":26,"bidPrice":81.4,"bidSize":44,"shortable":3,"etf":0,"ttmEps":-4.406658,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753819200000},"marketStatusCode":2,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":81.94,"preHourTrading":{"tag":"盘前","latestPrice":81.79,"preClose":81.94,"latestTime":"09:28 EDT","volume":3658,"amount":297441.96634,"timestamp":1753795725081},"postHourTrading":{"tag":"盘后","latestPrice":81.94,"preClose":81.94,"latestTime":"16:39 EDT","volume":13969,"amount":1144619.86,"timestamp":1753735182139},"volumeRatio":0.432061,"impliedVol":0.4591,"impliedVolPercentile":0.352},"requestUrl":"/m/hq/s/NUVL","defaultTab":"news","newsList":[{"id":"2546437902","title":"Baird：维持Nuvalent评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至112.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546437902","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546437902?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:23","pubTimestamp":1750857836,"startTime":"0","endTime":"0","summary":"Baird：维持Nuvalent(NUVL.US)评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至112.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625212941952b397b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625212941952b397b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"2539262463","title":"Nuvalent, Inc.盘中异动 股价大涨5.12%报75.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539262463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539262463?lang=zh_cn&edition=full","pubTime":"2025-05-30 00:05","pubTimestamp":1748534744,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日00时05分，Nuvalent, Inc.股票出现异动，股价大幅上涨5.12%。截至发稿，该股报75.09美元/股，成交量15.5106万股，换手率0.22%，振幅6.64%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053000054595071cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053000054595071cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2536584788","title":"Nuvalent, Inc.2025财年第一财季实现净利润-84.58百万美元，同比减少90.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536584788","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536584788?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497630,"startTime":"0","endTime":"0","summary":"5月18日，Nuvalent, Inc.公布财报，公告显示公司2025财年第一财季净利润为-84.58百万美元，同比减少90.15%；其中营业收入为0.00美元，每股基本收益为-1.18美元。从资产负债表来看，Nuvalent, Inc.总负债94.75百万美元，其中短期债务0.00美元，资产负债比为0.12，流动比率为0.15。机构评级：截至2025年5月18日，当前有10家机构对Nuvalent, Inc.目标价做出预测，其中目标均价为111.70美元，其中最低目标价为100.00美元，最高目标价为137.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000212a4821de3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000212a4821de3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"2534927904","title":"Nuvalent, Inc.盘中异动 早盘急速上涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534927904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534927904?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:38","pubTimestamp":1747057135,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时38分，Nuvalent, Inc.股票出现波动，股价大幅拉升5.91%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为2.81%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、艾吉纳斯涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为353.54%、73.42%、59.58%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、艾吉纳斯、Engene Holdings Inc.，振幅分别为49.55%、29.55%、21.28%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213855a47b79ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213855a47b79ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2533153962","title":"Nuvalent, Inc.盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533153962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533153962?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:43","pubTimestamp":1746719030,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时43分，Nuvalent, Inc.股票出现波动，股价急速拉升5.04%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为2.55%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Nucana Plc、Gri Bio, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为483.35%、113.00%、57.77%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为87.50%、59.60%、46.85%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823435097536482&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823435097536482&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2533506976","title":"Nuvalent, Inc.盘中异动 急速下跌5.01%报71.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533506976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533506976?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:45","pubTimestamp":1746549925,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时45分，Nuvalent, Inc.股票出现波动，股价急速跳水5.01%。截至发稿，该股报71.65美元/股，成交量13.9399万股，换手率0.19%，振幅4.04%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为5.44%。Nuvalent, Inc.公司简介：Nuvalent Inc 是一家临床阶段生物制药公司，专注于为癌症患者研发精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070045259750e4bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070045259750e4bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2526619387","title":"Nuvalent, Inc.盘中异动 快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526619387?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:40","pubTimestamp":1744393219,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时40分，Nuvalent, Inc.股票出现异动，股价急速拉升5.26%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2116.98%、1639.91%、398.80%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120140199735919c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120140199735919c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2518202206","title":"Nuvalent, Inc.盘中异动 急速下挫5.08%报67.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202206?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:13","pubTimestamp":1741634026,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时13分，Nuvalent, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报67.46美元/股，成交量71.6696万股，换手率1.00%，振幅3.74%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031346a26aa563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031346a26aa563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2517162594","title":"Nuvalent, Inc.2024财年实现净利润-2.61亿美元，同比减少107.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162594?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276864,"startTime":"0","endTime":"0","summary":"3月7日，Nuvalent, Inc.公布财报，公告显示公司2024财年净利润为-2.61亿美元，同比减少107.14%；其中营业收入为0.00美元，每股基本收益为-3.93美元。从资产负债表来看，Nuvalent, Inc.总负债71.96百万美元，其中短期债务0.00美元，资产负债比为0.16，流动比率为0.21。机构评级：截至2025年3月7日，当前有11家机构对Nuvalent, Inc.目标价做出预测，其中目标均价为113.73美元，其中最低目标价为100.00美元，最高目标价为137.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000122abeb8d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000122abeb8d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"1194057199","title":"Nuvalent 2024年第四季度每股亏损1.05美元，超出分析师预期的1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194057199","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194057199?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:40","pubTimestamp":1740656431,"startTime":"0","endTime":"0","summary":"Nuvalent报告其每股季度亏损1.05美元，超出分析师普遍预期的1.08美元，比预期高出2.78%。与去年同期的每股亏损0.62美元相比，亏损增加了69.35%。以上内容来自Benzinga Earnings专栏，原文如下：Nuvalent  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.78 percent. This is a 69.35 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Nuvalent 2024年第四季度每股亏损1.05美元，超出分析师预期的1.08美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"gpt_icon":0},{"id":"2509231289","title":"Nuvalent, Inc.盘中异动 快速拉升5.21%报90.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231289?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:51","pubTimestamp":1738774271,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时51分，Nuvalent, Inc.股票出现异动，股价快速拉升5.21%。截至发稿，该股报90.40美元/股，成交量11.0499万股，换手率0.16%，振幅5.74%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206005111a23a9a34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206005111a23a9a34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2503625354","title":"Nuvalent, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503625354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503625354?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:22","pubTimestamp":1736954562,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时22分，Nuvalent, Inc.股票出现波动，股价急速上涨5.01%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为204.99%、140.13%、77.83%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、61.30%、54.40%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152322429604c276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152322429604c276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2503589256","title":"Nuvalent, Inc.盘中异动 早盘快速下跌5.20%报72.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503589256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503589256?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:12","pubTimestamp":1736781160,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时12分，Nuvalent, Inc.股票出现波动，股价急速下跌5.20%。截至发稿，该股报72.63美元/股，成交量2.7987万股，换手率0.04%，振幅4.60%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323124196025b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323124196025b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2492159090","title":"Nuvalent, Inc.盘中异动 临近收盘股价大跌5.12%报83.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159090?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:40","pubTimestamp":1734554406,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时40分，Nuvalent, Inc.股票出现异动，股价急速下挫5.12%。截至发稿，该股报83.59美元/股，成交量18.4705万股，换手率0.26%，振幅4.67%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为2.83%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904400795ea5ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904400795ea5ae9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2490077381","title":"Nuvalent, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490077381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490077381?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:32","pubTimestamp":1734013934,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时32分，Nuvalent, Inc.股票出现波动，股价大幅跳水5.12%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Palisade Bio, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1909.98%、448.84%、50.59%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aptevo Therapeutics Inc.、Palisade Bio, Inc.，振幅分别为54.53%、17.38%、17.14%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223214ab72a87a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223214ab72a87a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2484691559","title":"Nuvalent, Inc.2024财年第三财季实现净利润-84.35百万美元，同比减少150.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484691559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484691559?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010412,"startTime":"0","endTime":"0","summary":"11月19日，Nuvalent, Inc.公布财报，公告显示公司2024财年第三财季净利润为-84.35百万美元，同比减少150.67%；其中营业收入为0.00美元，每股基本收益为-1.28美元。从资产负债表来看，Nuvalent, Inc.总负债67.73百万美元，其中短期债务0.00美元，资产负债比为0.18，流动比率为0.24。机构评级：截至2024年11月19日，当前有12家机构对Nuvalent, Inc.目标价做出预测，其中目标均价为115.83美元，其中最低目标价为100.00美元，最高目标价为137.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180020a245619e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180020a245619e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"2477042538","title":"Nuvalent, Inc.跌5.08% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2477042538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477042538?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690271,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Nuvalent, Inc.股票出现异动，股价大幅下跌5.08%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Dbv Technologies涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为842.55%、474.19%、266.63%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Okyo Pharma Ltd Com Npv ，振幅分别为27.06%、17.26%、13.56%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311195bd428c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311195bd428c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2474443547","title":"Nuvalent, Inc.跌1.46% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2474443547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474443547?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:57","pubTimestamp":1728568675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时57分，Nuvalent, Inc.股票出现异动，股价快速下挫1.46%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为210.06%、128.20%、104.09%，振幅较大的相关个股有Genenta Science Spa、Tevogen Bio Holdings Inc.、Gri Bio, Inc.，振幅分别为25.48%、20.40%、18.60%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021575598e3bbbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021575598e3bbbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2472937770","title":"Nuvalent, Inc.跌2.25% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2472937770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472937770?lang=zh_cn&edition=full","pubTime":"2024-10-01 23:02","pubTimestamp":1727794969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日23时02分，Nuvalent, Inc.股票出现异动，股价快速下跌2.25%。截至发稿，该股报100.00美元/股，成交量17.1446万股，换手率0.24%，振幅2.14%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012302499719db98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012302499719db98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2471857953","title":"Nuvalent, Inc.涨1.58% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2471857953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471857953?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:48","pubTimestamp":1727704136,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时48分，Nuvalent, Inc.股票出现异动，股价快速上涨1.58%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Prime Medicine, Inc.、Kezar Life Sciences, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Aditxt, Inc.、Onconetix, Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为56.35%、22.99%、22.59%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Cingulate Inc C/Wts 10/12/2026 、Plus Therapeutics, Inc.，振幅分别为32.54%、31.55%、28.10%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302148569719d9a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302148569719d9a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuvalent.com","stockEarnings":[{"period":"1week","weight":-0.0063},{"period":"1month","weight":0.0284},{"period":"3month","weight":0.08},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.004},{"period":"ytd","weight":0.0468}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuvalent, Inc.于2017年1月25日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。该公司利用团队在化学和基于结构的药物设计方面的深厚专业知识，开发创新的小分子，其设计旨在克服现有疗法对临床证明的激酶靶点的限制。目前可用的激酶抑制剂面临的限制可能包括（i）激酶耐药性，或激酶靶点出现新的突变，从而能够对现有疗法产生耐药性，（ii）激酶选择性，或现有疗法可能抑制结构相似的激酶靶点并导致脱靶不良事件，以及（iii）有限的脑外显率，或该疗法治疗已经扩散或转移到大脑的疾病的能力。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.039512},{"month":2,"riseRate":0.75,"avgChangeRate":0.025601},{"month":3,"riseRate":0,"avgChangeRate":-0.092764},{"month":4,"riseRate":0.5,"avgChangeRate":0.024196},{"month":5,"riseRate":0.25,"avgChangeRate":-0.006145},{"month":6,"riseRate":1,"avgChangeRate":0.177709},{"month":7,"riseRate":1,"avgChangeRate":0.101423},{"month":8,"riseRate":0.75,"avgChangeRate":0.277791},{"month":9,"riseRate":0.75,"avgChangeRate":-0.004719},{"month":10,"riseRate":0.75,"avgChangeRate":0.22961},{"month":11,"riseRate":0.5,"avgChangeRate":0.035338},{"month":12,"riseRate":0.25,"avgChangeRate":-0.066554}],"exchange":"NASDAQ","name":"Nuvalent, Inc.","nameEN":"Nuvalent, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuvalent, Inc.,NUVL,Nuvalent, Inc.股票,Nuvalent, Inc.股票老虎,Nuvalent, Inc.股票老虎国际,Nuvalent, Inc.行情,Nuvalent, Inc.股票行情,Nuvalent, Inc.股价,Nuvalent, Inc.股市,Nuvalent, Inc.股票价格,Nuvalent, Inc.股票交易,Nuvalent, Inc.股票购买,Nuvalent, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}